Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin CVitamin C (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Clinical Characteristics and Mortality Trends Among COVID-19 Patients During the First Four Waves in Ngaliema Clinic, Democratic Republic of the Congo

Bepouka et al., Infection and Drug Resistance, doi:10.2147/IDR.S499371, May 2025
https://c19early.org/bepouka.html
Mortality 76% Improvement Relative Risk Vitamin C for COVID-19  Bepouka et al.  LATE TREATMENT Is late treatment with vitamin C beneficial for COVID-19? Retrospective 410 patients in DR Congo (March 2020 - January 2022) Lower mortality with vitamin C (p=0.01) c19early.org Bepouka et al., Infection and Drug Res.., May 2025 Favorsvitamin C Favorscontrol 0 0.5 1 1.5 2+
Vitamin C for COVID-19
6th treatment shown to reduce risk in September 2020, now with p = 0.00000002 from 75 studies, recognized in 22 countries.
Lower risk for mortality, ICU, hospitalization, and recovery.
No treatment is 100% effective. Protocols combine treatments.
5,700+ studies for 161 treatments. c19early.org
Retrospective 410 hospitalized COVID-19 patients in the Democratic Republic of Congo showing significantly lower mortality with vitamin C treatment.
This is the 75th COVID-19 controlled study for vitamin C, which collectively show efficacy with p=0.00000002 (1 in 50 million).
21 studies are RCTs, which show efficacy with p=0.0012.
risk of death, 76.0% lower, OR 0.24, p = 0.01, treatment 185, control 225, adjusted per study, multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Bepouka et al., 14 May 2025, retrospective, DR Congo, peer-reviewed, 14 authors, study period 20 March, 2020 - 2 January, 2022. Contact: benbepouka@gmail.com.
Clinical Characteristics and Mortality Trends Among COVID-19 Patients During the First Four Waves in Ngaliema Clinic, Democratic Republic of the Congo
Ben Bepouka, Madone Mandina, Daniel Mvibudulu, Junior Matangila, Armand Okamba, Gertrude Muyeke, Dieudonne Tawaba, Nadine Mayasi, Ossam Odio, Donat Mangala, Tuna Lukiana, Marcel Mbula, Hippolyte Situakibanza, Murielle Longokolo
Infection and Drug Resistance, doi:10.2147/idr.s499371
Background: COVID-19 disease has been a deadly pandemic in different waves in the Democratic Republic of Congo. However, knowledge of the clinical characteristics of COVID-19 patients and the factors associated with death during different waves is important. Methods: We conducted a retrospective cohort of 410 patients hospitalized during 4 waves of COVID-19, from March 20, 2020, to January 2, 2022, at the Ngaliema clinic in DR Congo. We included any patient hospitalized for COVID-19 with biological confirmation by RT-PCR. Factors associated with death were investigated using logistic regression. Results: During the 4 waves of the COVID-19 pandemic at Clinique Ngaliema, complaints on admission were most often fever, cough and physical asthenia. Death was most common in the elderly, hypertensive and diabetic patients, those with elevated CRP and hyper leukocytosis. Mortality was highest in the 1st wave (28%), followed by the 3rd wave (27%), then the 2nd (22%) and 4th waves (21%). Factors associated with death were hyper leukocytosis (ORa: 2.76; CI 95%: 1.25-6.1), severe disease stage (ORa 21.24; CI 95%: 1.87-24). Vitamin C 500 mg twice a day use was protective (ORa: 0.24; CI 95%: 0.08-0.72). Conclusion: COVID-19 disease poses a real public health problem, with non-negligible mortality. Factors associated with death were degree of disease severity, hyper leukocytosis and non-use of vitamin C. Taking these factors into account will help clinicians and decision-makers to anticipate future waves of the pandemic.
Disclosure The authors report no competing interests in this work.
References
Abdullah, Chai, Chong, Gender effect on in vitro lymphocyte subset levels of healthy individuals, Cell Immunol, doi:10.1016/j.cellimm.2011.10.009
Abobaker, Alzwi, Alraied, Overview of the possible role of vitamin C in management of COVID-19, Pharmacol Rep, doi:10.1007/s43440-020-00176-1
Abraha, Gessesse, Gebrecherkos, Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia, Int J Infect Dis, doi:10.1016/j.ijid.2021.03.037
Armstrong, Kane, Kursumovic, Oglesby, Cook, Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies, Anaesthesia, doi:10.1111/anae.15425
Bepouka, Mandina, Makulo, Predictors of mortality in COVID-19 patients at Kinshasa UniversityHospital, Democratic Republic of the Congo, from March to June 2020, Pan Afr Med J, doi:10.11604/pamj.2020.37.105.25279
Bepouka, Odio, Mangala, Diabetes mellitus is associated with higher COVID-19 mortality rates in Sub-Saharan Africa: a systematic review and meta-analysis, Cureus, doi:10.7759/cureus.26877
Bepouka, Situakibanza, Sangare, Mortality associated with COVID-19 and hypertension in sub-Saharan Africa. A systematic review and meta-analysis, J Clin Hypertens, doi:10.1111/jch.14417
Betjes, Immune cell dysfunction and inflammation in end-stage renal disease [J], Nat Rev Nephrol, doi:10.1038/nrneph.2013.44
Boulle, Davies, Hussey, Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa, Clin Infect Dis, doi:10.1093/cid/ciaa1198
Bright, Babalola, Sam-Agudu, COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-saharan Africa, Global Health, doi:10.1186/s12992-021-00668-6
Brown, Spinelli, Gandhi, The interplay between HIV and COVID-19: summary of the data and responses to date, Curr Opin HIV AIDS, doi:10.1097/COH.0000000000000659
Cai, Zhang, Zhu, Liu, Liu et al., Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis, Int Urol Nephrol, doi:10.1007/s11255-020-02740-3
Chen, Klein, Garibaldi, Aging in COVID-19: vulnerability, immunity and intervention, Ageing Res Rev, doi:10.1016/j.arr.2020.101205
Dessie, Zewotir, Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients, BMC Infect Dis, doi:10.1186/s12879-021-06536-3
Elimian, Ochu, Ebhodaghe, Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort study, BMJ Open, doi:10.1136/bmjopen-2020-044079
Farsalinos, Barbouni, Niaura, Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern, Emerg. Med
Hewagama, Patel, Yarlagadda, Strickland, Richardson, Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis, Genes Immun, doi:10.1038/gene.2009.12
Hubbard, Maier, Hilmer, Frailty in the face of COVID-19: a systematic review and meta-analysis, JAMA Netw Open, doi:10.1001/jamanetworkopen.2021.15185
Inandiklioglu, Akkoc, Immune responses to SARS-CoV, MERS-CoV and SARS-CoV-2, Adv. Exp. Med. Biol
Lee, Gardner, Porter, Current concepts in the diagnosis and management of cytokine release syndrome, Blood, doi:10.1182/blood-2014-05-552729
Liu, Zhou, Yang, The cytokine storm of severe influenza and development of immunomodulatory therapy, Cellular & Molecular Immunology, doi:10.1038/cmi.2015.74
Makulo, Wumba, Mandina, SARS-CoV2 mutations and impact on mortality: observational study in a sub-saharan Africa hospital, Virol J, doi:10.1186/s12985-023-02014-1
Matangila, Nyembu, Telo, Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: a retrospective cohort study, PLoS One, doi:10.1371/journal.pone.0244272
Mehta, Pokharna, Shetty, epidemiology of antibiotic resistance and the mechanisms of resistance development and diffusion in both hospitals and the community, doi:10.1177/02601060221139628
Minchella, Chanda, Hines, Clinical characteristics and outcomes of patients hospitalized with COVID-19 during the first 4 waves in Zambia, JAMA Netw Open, doi:10.1001/jamanetworkopen.2022.46152
Nachega, Ishoso, Otokoye, Clinical characteristics and outcomes of patients hospitalized for COVID-19 in Africa: early Insights from the Democratic Republic of the Congo, Am J Trop Med Hyg, doi:10.4269/ajtmh.20-1240
Nlandu, Mafuta, Sakaji, Predictors of mortality in COVID-19 patients at Kinshasa Medical Center and a survival analysis: a retrospective cohort study, BMC Infect Dis, doi:10.1186/s12879-021-06984-x
Osibogun, Balogun, Abayomi, Outcomes of COVID-19 patients with comorbidities in southwest Nigeria, PLoS One, doi:10.1371/journal.pone.0248281
Otshudiema, Folefack, Nsio, Epidemiological comparison of four COVID-19 waves in the Democratic Republic of the Congo, March 2020-January 2022, J Epidemiol Glob Health, doi:10.1007/s44197-022-00052-6
Parohan, Yaghoubi, Seraji, Javanbakht, Sarraf et al., Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies, The Aging Male, doi:10.1080/13685538.2020.1774748
Sabino, Buss, Carvalho, Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence, Lancet, doi:10.1016/S0140-6736(21)00183-5
Sen-Crowe, Sutherland, Mckenney, Elkbuli, A closer look into global hospital beds capacity and resource shortages during the COVID-19 Pandemic, J Surg Res, doi:10.1016/j.jss.2020.11.062
Shimabukuro-Vornhagen, Gödel, Subklewe, Cytokine release syndrome, Journal for Immunotherapy of Cancer, doi:10.1186/s40425-018-0343-9
Tang, Tambyah, Hui, Emergence of a new SARS-CoV-2 variant in the UK, J Infect, doi:10.1016/j.jinf.2020.12.024
Tisoncik, Korth, Simmons, Into the eye of the cytokine storm, Microbiol. Mol. Biol. Rev, doi:10.1128/MMBR.05015-11
Wiersinga, Rhodes, Cheng, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review, JAMA, doi:10.1001/jama.2020.12839
Wolter, Jassat, Walaza, Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study, Lancet, doi:10.1016/S0140-6736(22)00017-4
Wong, Viswanathan, Wang, Current and future developments in the treatment of virus-induced hypercytokinemia, Future Med. Chem, doi:10.4155/fmc-2016-0181
DOI record: { "DOI": "10.2147/idr.s499371", "ISSN": [ "1178-6973" ], "URL": "http://dx.doi.org/10.2147/IDR.S499371", "author": [ { "affiliation": [], "family": "Bepouka", "given": "Ben", "sequence": "first" }, { "affiliation": [], "family": "Mandina", "given": "Madone", "sequence": "additional" }, { "affiliation": [], "family": "Mvibudulu", "given": "Daniel", "sequence": "additional" }, { "affiliation": [], "family": "Matangila", "given": "Junior", "sequence": "additional" }, { "affiliation": [], "family": "Okamba", "given": "Armand", "sequence": "additional" }, { "affiliation": [], "family": "Muyeke", "given": "Gertrude", "sequence": "additional" }, { "affiliation": [], "family": "Tawaba", "given": "Dieudonne", "sequence": "additional" }, { "affiliation": [], "family": "Mayasi", "given": "Nadine", "sequence": "additional" }, { "affiliation": [], "family": "Odio", "given": "Ossam", "sequence": "additional" }, { "affiliation": [], "family": "Mangala", "given": "Donat", "sequence": "additional" }, { "affiliation": [], "family": "Lukiana", "given": "Tuna", "sequence": "additional" }, { "affiliation": [], "family": "Mbula", "given": "Marcel", "sequence": "additional" }, { "affiliation": [], "family": "Situakibanza", "given": "Hippolyte", "sequence": "additional" }, { "affiliation": [], "family": "Longokolo", "given": "Murielle", "sequence": "additional" } ], "container-title": "Infection and Drug Resistance", "container-title-short": "IDR", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2025, 5, 14 ] ], "date-time": "2025-05-14T07:30:11Z", "timestamp": 1747207811000 }, "deposited": { "date-parts": [ [ 2025, 5, 14 ] ], "date-time": "2025-05-14T07:30:21Z", "timestamp": 1747207821000 }, "indexed": { "date-parts": [ [ 2025, 5, 15 ] ], "date-time": "2025-05-15T04:08:17Z", "timestamp": 1747282097795, "version": "3.40.5" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 5 ] ] }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc/3.0/", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 5, 1 ] ], "date-time": "2025-05-01T00:00:00Z", "timestamp": 1746057600000 } } ], "link": [ { "URL": "https://www.dovepress.com/article/download/102933", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.dovepress.com/article/download/102933", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "301", "original-title": [], "page": "2525-2536", "prefix": "10.2147", "published": { "date-parts": [ [ 2025, 5 ] ] }, "published-online": { "date-parts": [ [ 2025, 5 ] ] }, "publisher": "Informa UK Limited", "reference": [ { "key": "ref1", "unstructured": "World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int. Accessed January 10, 2023." }, { "DOI": "10.1016/j.jss.2020.11.062", "author": "Sen-crowe", "doi-asserted-by": "publisher", "first-page": "56", "journal-title": "J Surg Res", "key": "ref2", "volume": "260", "year": "2020" }, { "DOI": "10.1001/jamanetworkopen.2022.46152", "author": "Minchella", "doi-asserted-by": "publisher", "first-page": "e2246152", "journal-title": "JAMA Netw Open", "key": "ref3", "volume": "5", "year": "2022" }, { "DOI": "10.1111/anae.15425", "author": "Armstrong", "doi-asserted-by": "publisher", "first-page": "537", "journal-title": "Anaesthesia", "key": "ref4", "volume": "76", "year": "2021" }, { "DOI": "10.1007/s43440-020-00176-1", "author": "Abobaker", "doi-asserted-by": "publisher", "first-page": "1517", "journal-title": "Pharmacol Rep", "key": "ref5", "volume": "72", "year": "2020" }, { "DOI": "10.1016/S0140-6736(21)00183-5", "author": "Sabino", "doi-asserted-by": "publisher", "first-page": "452", "journal-title": "Lancet", "key": "ref6", "volume": "397", "year": "2021" }, { "DOI": "10.1016/j.jinf.2020.12.024", "author": "Tang", "doi-asserted-by": "publisher", "first-page": "e27", "journal-title": "J Infect", "key": "ref7", "volume": "82", "year": "2021" }, { "key": "ref8", "unstructured": "Africa CDC. (2020). COVID-19 situation in Africa: annual report 2020. African Union. Available from: https://africacdc.org/download/africa-cdc-annual-report-2020/. Accessed May 12, 2025." }, { "key": "ref9", "unstructured": "World Health Organization Regional Office for Africa. (2021). Weekly bulletin on COVID-19 in the African region (30 July 2021). WHO. Available from: https://www.afro.who.int/node/12296. Accessed May 12, 2025." }, { "key": "ref10", "unstructured": "Available from: https://www.nicd.ac.za/wp-content/uploads/2022/03/COVID-19-Waves-Comparison_NICD_March2022.pdf. Accessed May 12, 2025." }, { "DOI": "10.1016/S0140-6736(22)00017-4", "author": "Wolter", "doi-asserted-by": "publisher", "first-page": "437", "journal-title": "Lancet", "key": "ref11", "volume": "399", "year": "2022" }, { "key": "ref12", "unstructured": "Available from: https://reliefweb.int/report/democratic-republic-congo/last-mile-covid-19-vaccines-drc. Accessed May 12, 2025." }, { "DOI": "10.1186/s12992-021-00668-6", "author": "Bright", "doi-asserted-by": "publisher", "first-page": "24", "journal-title": "Global Health", "key": "ref13", "volume": "17", "year": "2021" }, { "DOI": "10.1186/s12985-023-02014-1", "author": "Makulo", "doi-asserted-by": "publisher", "first-page": "56", "journal-title": "Virol J", "key": "ref14", "volume": "20", "year": "2023" }, { "DOI": "10.11604/pamj.2020.37.105.25279", "author": "Bepouka", "doi-asserted-by": "publisher", "first-page": "105", "journal-title": "Pan Afr Med J", "key": "ref15", "volume": "37", "year": "2020" }, { "DOI": "10.1371/journal.pone.0244272", "author": "Matangila", "doi-asserted-by": "publisher", "first-page": "e0244272", "journal-title": "PLoS One", "key": "ref16", "volume": "15", "year": "2020" }, { "DOI": "10.4269/ajtmh.20-1240", "author": "Nachega", "doi-asserted-by": "publisher", "first-page": "2419", "journal-title": "Am J Trop Med Hyg", "key": "ref17", "volume": "103", "year": "2020" }, { "DOI": "10.1186/s12879-021-06984-x", "author": "Nlandu", "doi-asserted-by": "publisher", "first-page": "1272", "journal-title": "BMC Infect Dis", "key": "ref18", "volume": "21", "year": "2021" }, { "DOI": "10.1007/s44197-022-00052-6", "author": "Otshudiema", "doi-asserted-by": "publisher", "first-page": "316", "journal-title": "J Epidemiol Glob Health", "key": "ref19", "volume": "12", "year": "2022" }, { "DOI": "10.15557/PiMR.2020.0003", "doi-asserted-by": "crossref", "key": "ref20", "unstructured": "World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected interim guidance, 13 March 2020. World Health Organization." }, { "DOI": "10.1001/jamanetworkopen.2021.15185", "author": "Hubbard", "doi-asserted-by": "publisher", "first-page": "e2115185", "journal-title": "JAMA Netw Open", "key": "ref21", "volume": "4", "year": "2021" }, { "key": "ref22", "unstructured": "République Démocratique du Congo. Guide de prise en charge de l´épidémie à COVID-19. République Démocratique du Congo. 2020." }, { "DOI": "10.1016/j.ijid.2021.03.037", "author": "Abraha", "doi-asserted-by": "publisher", "first-page": "776", "journal-title": "Int J Infect Dis", "key": "ref23", "volume": "105", "year": "2021" }, { "DOI": "10.1371/journal.pone.0248281", "author": "Osibogun", "doi-asserted-by": "publisher", "first-page": "e0248281", "journal-title": "PLoS One", "key": "ref24", "volume": "16", "year": "2021" }, { "DOI": "10.1093/cid/ciaa1198", "author": "Boulle", "doi-asserted-by": "publisher", "first-page": "ciaa1198", "journal-title": "Clin Infect Dis", "key": "ref25", "year": "2020" }, { "DOI": "10.1136/bmjopen-2020-044079", "author": "Elimian", "doi-asserted-by": "publisher", "first-page": "e044079", "journal-title": "BMJ Open", "key": "ref26", "volume": "10", "year": "2020" }, { "DOI": "10.1016/j.arr.2020.101205", "author": "Chen", "doi-asserted-by": "publisher", "first-page": "101205", "journal-title": "Ageing Res Rev", "key": "ref27", "volume": "65", "year": "2021" }, { "DOI": "10.1038/gene.2009.12", "author": "Hewagama", "doi-asserted-by": "publisher", "first-page": "509", "journal-title": "Genes Immun", "key": "ref28", "volume": "10", "year": "2009" }, { "DOI": "10.1016/j.cellimm.2011.10.009", "author": "Abdullah", "doi-asserted-by": "publisher", "first-page": "214", "journal-title": "Cell Immunol", "key": "ref29", "volume": "272", "year": "2012" }, { "DOI": "10.1080/13685538.2020.1774748", "author": "Parohan", "doi-asserted-by": "publisher", "first-page": "1416", "journal-title": "The Aging Male", "key": "ref30", "volume": "23", "year": "2020" }, { "DOI": "10.1186/s12879-021-06536-3", "author": "Dessie", "doi-asserted-by": "publisher", "first-page": "855", "journal-title": "BMC Infect Dis", "key": "ref31", "volume": "21", "year": "2021" }, { "DOI": "10.7759/cureus.26877", "author": "Bepouka", "doi-asserted-by": "publisher", "first-page": "e26877", "journal-title": "Cureus", "key": "ref32", "volume": "14", "year": "2022" }, { "DOI": "10.1111/jch.14417", "author": "Bepouka", "doi-asserted-by": "publisher", "first-page": "99", "journal-title": "J Clin Hypertens", "key": "ref33", "volume": "24", "year": "2022" }, { "DOI": "10.1007/s11255-020-02740-3", "author": "Cai", "doi-asserted-by": "publisher", "first-page": "1623", "journal-title": "Int Urol Nephrol", "key": "ref34", "volume": "53", "year": "2021" }, { "DOI": "10.1038/nrneph.2013.44", "author": "Betjes", "doi-asserted-by": "publisher", "first-page": "255", "journal-title": "Nat Rev Nephrol", "key": "ref35", "volume": "9", "year": "2013" }, { "DOI": "10.1097/COH.0000000000000659", "author": "Brown", "doi-asserted-by": "publisher", "first-page": "63", "journal-title": "Curr Opin HIV AIDS", "key": "ref36", "volume": "16", "year": "2021" }, { "author": "Farsalinos", "first-page": "1", "journal-title": "Intern. Emerg. Med", "key": "ref37", "volume": "2020", "year": "2020" }, { "DOI": "10.4155/fmc-2016-0181", "author": "Wong", "doi-asserted-by": "publisher", "first-page": "169", "journal-title": "Future Med. Chem", "key": "ref38", "volume": "9", "year": "2017" }, { "DOI": "10.1038/cmi.2015.74", "author": "Liu", "doi-asserted-by": "publisher", "first-page": "3", "journal-title": "Cellular & Molecular Immunology", "key": "ref39", "volume": "13", "year": "2016" }, { "DOI": "10.1128/MMBR.05015-11", "author": "Tisoncik", "doi-asserted-by": "publisher", "first-page": "16", "journal-title": "Microbiol. Mol. Biol. Rev", "key": "ref40", "volume": "76", "year": "2012" }, { "DOI": "10.1186/s40425-018-0343-9", "author": "Shimabukuro-Vornhagen", "doi-asserted-by": "publisher", "first-page": "56", "journal-title": "Journal for Immunotherapy of Cancer", "key": "ref41", "volume": "6", "year": "2018" }, { "DOI": "10.1182/blood-2014-05-552729", "author": "Lee", "doi-asserted-by": "publisher", "first-page": "188", "journal-title": "Blood", "key": "ref42", "volume": "124", "year": "2014" }, { "DOI": "10.1001/jama.2020.12839", "author": "Wiersinga", "doi-asserted-by": "publisher", "first-page": "782", "journal-title": "JAMA", "key": "ref43", "volume": "324", "year": "2020" }, { "DOI": "10.1007/5584_2020_549", "author": "Inandiklioglu", "doi-asserted-by": "crossref", "first-page": "5", "journal-title": "Adv. Exp. Med. Biol", "key": "ref44", "volume": "9", "year": "2020" }, { "DOI": "10.1177/02601060221139628", "author": "Mehta", "doi-asserted-by": "publisher", "first-page": "415", "journal-title": "Nutr Health", "key": "ref45", "volume": "29", "year": "2023" } ], "reference-count": 45, "references-count": 45, "relation": {}, "resource": { "primary": { "URL": "https://www.dovepress.com/clinical-characteristics-and-mortality-trends-among-covid-19-patients--peer-reviewed-fulltext-article-IDR" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Clinical Characteristics and Mortality Trends Among COVID-19 Patients During the First Four Waves in Ngaliema Clinic, Democratic Republic of the Congo", "type": "journal-article", "volume": "Volume 18" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit